Antitumor properties of 1,3-oxazine derivatives. I. Derivatives of 5-nitrotetrahydro-1,3-oxazines.
D000654:Amobarbital; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy / Q000201:enzymology; D008223:Lymphoma / Q000188:drug therapy / Q000201:enzymology; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy* / Q000201:enzymology; D010078:Oxazines / Q000494:pharmacology / Q000627:therapeutic use*; D010088:Oxidoreductases / Q000032:analysis; D012509:Sarcoma / Q000139:chemically induced / Q000188:drug therapy / Q000201:enzymology; D012510:Sarcoma 180 / Q000188:drug therapy / Q000201:enzymology; D012513:Sarcoma, Experimental / Q000188:drug therapy / Q000201:enzymology
D000970:Antineoplastic Agents; D010078:Oxazines; D010088:Oxidoreductases; D000654:Amobarbital